Eating disorders such as anorexia and bulimia are among the most dangerous mental health conditions, with particularly high mortality rates in adolescents. Early detection and continuous monitoring are crucial, yet traditional approaches often rely on family supervision or occasional clinical visits, leaving gaps in care and increasing the risk of chronicity.
This is the challenge that Psifiacos aims to solve with ANNi, its real-time remote monitoring platform. By combining proprietary algorithms, artificial intelligence, and wearable devices, ANNi provides continuous tracking of physiological biomarkers to detect risks early, issue preventive alerts, and support timely interventions. This reduces the burden on families, improves clinical outcomes, and offers flexibility for use in both healthcare settings and home environments.
Founded by Dr. Boris C. Rodríguez Martín, a clinical psychologist with over 25 years of expertise in eating disorders, and Dr. Saira R. Rivas Suárez, a family medicine and medical psychology specialist, Psifiacos brings deep clinical knowledge into the digital health space. Their hybrid B2B and B2C subscription model is designed for families, healthcare professionals, clinics, treatment centers, and insurers, ensuring both scalability and accessibility.
While challenges remain in integrating wearable devices from multiple manufacturers and meeting regulatory standards for CE certification, Psifiacos is committed to empowering families and clinicians with innovative tools. Since 2022, the startup has raised €150,000 through private and public funding, and is now seeking €500,000 to achieve certification, strengthen its technical and clinical teams, and scale its go-to-market strategy.
Through initiatives like Al Andalus Innovation Venture, Psifiacos seeks not only visibility and networking with investors but also strategic partnerships with clinics and insurers to expand its impact across Andalusia and Southern Europe. Ultimately, ANNi’s mission is to democratize access to continuous clinical monitoring, reduce mortality, and improve the quality of life for adolescents affected by eating disorders and their families.
Artículo escrito por el equipo de redacción de El Referente
21/09/2025
Source:
El referente